Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression (Q34177975)

31 July 2017

title

Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression (English)

1 reference

31 July 2017

3

Abraham Weizman

1 reference

31 July 2017

Karin Schwartz

1

1 reference

31 July 2017

Gal Yadid

series ordinal

2

1 reference

31 July 2017

Moshe Rehavi

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

31 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

31 July 2017

volume

965

1 reference

31 July 2017

issue

1-2

1 reference

31 July 2017

page(s)

174-179

1 reference

Neurotransmitter transporters: three distinct gene families.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Lithium ions modulate the expression of VMAT2 in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Quantitative autoradiography of the rat brain vesicular monoamine transporter using the binding of [3H]dihydrotetrabenazine and 7-amino-8-[125I]iodoketanserin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Functional identification and molecular cloning of a human brain vesicle monoamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

The neuronal monoamine transporter VMAT2 is regulated by the trimeric GTPase Go(2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

The Flinders sensitive line rats: a genetic animal model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Altered gene expression for catecholamine biosynthetic enzymes and stress response in rat genetic model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Tritiated imipramine binding sites are decreased in the frontal cortex of suicides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Imipramine treatment differentially affects platelet 3H-imipramine binding and serotonin uptake in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Synaptotagmin IV is an immediate early gene induced by depolarization in PC12 cells and in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Elucidation of the neurobiology of depression: insights from a novel genetic animal model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

High Serotonin and 5‐Hydroxyindoleacetic Acid Levels in Limbic Brain Regions in a Rat Model of Depression; Normalization by Chronic Antidepressant Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Increased catecholamine levels in specific brain regions of a rat model of depression: normalization by chronic antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat Substantia nigra and prefrontal cortex induced by psychotropic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Characterization of high-affinity [3H]TBZOH binding to the human platelet vesicular monoamine transporter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

Elevated platelet vesicular monoamine transporter density in untreated patients diagnosed with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-8993(02)04167-7

10.1016/S0006-8993(02)04167-7

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference